InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.
IVRO stock price ended at $0.14 on 月曜日, after dropping 6.67%
On the latest trading day Jan 26, 2026, the stock price of IVRO fell by 6.67%, dropping from $0.14 to $0.14. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.14 and a high of $0.14. On the latest trading day, the trading volume for IVRO decreased by 65.8K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.9K shares were traded, with a market value of approximately $3.1M.